Publications by authors named "Youngho Moon"

Introduction: Following the Republic of Korea electric power industry site-specific safety management system, this paper proposes a novel safety autonomous platform (SAP) architecture that can automatically and precisely manage on-site safety through ensemble artificial intelligence (AI) models. The ensemble AI model was generated from video information and worker's biometric information as learning data and the estimation results of this model are based on standard operating procedures of the workplace and safety rules.

Methods: The ensemble AI model is designed and implemented by the Hadoop ecosystem with Kafka/NiFi, Spark/Hive, HUE, and ELK (Elasticsearch, Logstash, Kibana).

View Article and Find Full Text PDF

Halitosis is mainly caused by the action of oral microbes. The purpose of this study was to investigate the differences in salivary microbes and metabolites between subjects with and without halitosis. Of the 52 participants, 22 were classified into the halitosis group by the volatile sulfur compound analysis on breath samples.

View Article and Find Full Text PDF

Background: The prognostic or predictive value of commonly used multigene assays in young patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) early breast cancer is unclear. In this study, we assessed the prognostic value of the GenesWell BCT assay according to age group.

Methods: We identified patients with pN0-1, HR+/HER2- breast cancer in a prospective cohort of women who underwent surgery between 2005 and 2017.

View Article and Find Full Text PDF
Article Synopsis
  • - The GenesWell Breast Cancer Test (BCT) is a new multigene assay designed to predict the risk of distant recurrence in early-stage breast cancer patients, specifically comparing its effectiveness to the Oncotype DX test in Asian patients.
  • - A study involving 771 Korean patients found that the BCT categorized 68.4% as low risk while Oncotype DX's risk groups showed a different distribution with only 17.4% classified as low risk.
  • - The two tests showed a 71.9% concordance overall, but had low agreement in patients aged 50 or younger and those with lymph node-positive breast cancer, indicating a need for further research in these specific groups.
View Article and Find Full Text PDF

In clinical translational research and molecular in vitro diagnostics, a major challenge in the detection of genetic mutations is overcoming artefactual results caused by the low-quality of formalin-fixed paraffin-embedded tissue (FFPET)-derived DNA (FFPET-DNA). Here, we propose the use of an 'internal quality control (iQC) index' as a criterion for judging the minimum quality of DNA for PCR-based analyses. In a pre-clinical study comparing the results from droplet digital PCR-based EGFR mutation test (ddEGFR test) and qPCR-based EGFR mutation test (cobas EGFR test), iQC index ≥ 0.

View Article and Find Full Text PDF

To make an optimal treatment decision for early stage breast cancer, it is important to identify risk of recurrence. Here, we developed and validated a new prognostic model for predicting the risk of distant metastasis in patients with pN0-N1, hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer treated with hormone therapy alone. RNA was extracted from formalin-fixed, paraffin-embedded tumor tissues and gene expression was measured by quantitative real-time reverse transcription-PCR.

View Article and Find Full Text PDF

Aberrant DNA methylation has shown promise as a biomarker for the early detection of cancer. To discover novel genes frequently methylated at an early stage in colorectal cancer (CRC), DNA microarray analysis coupled with enriched methylated DNA was performed in primary tumors and compared with adjacent nontumor tissues of 12 patients with CRC at stages I to IV. Stepwise filtering for candidate selection in microarray data analysis yielded a set of genes that are highly methylated across all CRC tumors and that can be used as a composite biomarker for CRC detection.

View Article and Find Full Text PDF

Rheumatoid arthritis (RA) is a chronic, systemic inflammatory disease of unknown origin, which exhibits a complex heterogeneity in its pathophysiological background, resulting in differential responses to a range of therapies and poor long-term prognosis. RA synovial fibroblasts (RASFs) are key player cells in RA pathogenesis. Identification of DNA methylation biomarkers is a field that provides potential for improving the process of diagnosis and prognosis of various human diseases.

View Article and Find Full Text PDF

Herein, we describe a novel multiplex genotyping method, GTPlex-PyroSeq. This method consists of two phases: multiplex PCR followed by a single reaction of pyrosequencing. This study demonstrates how GTPlex-PyroSeq can be adapted for the determination of multiple human papillomavirus (HPV) genotypes.

View Article and Find Full Text PDF

Aberrant DNA methylation occurs early and frequently in tumorigenesis. Identification of DNA methylation biomarkers is a field that provides potential for improving the clinical process of breast cancer diagnosis. We utilized a genome-wide technique, methylated DNA isolation assay (MeDIA), in combination with high-resolution CpG microarray analysis to identify hypermethylated genes in breast cancer.

View Article and Find Full Text PDF

Aberrant methylation of CpG islands in the promoter region of genes is a common epigenetic phenomenon found in early cancers. Therefore conducting genome-scale methylation studies will enhance our understanding of the epigenetic etiology behind carcinogenesis by providing reliable biomarkers for early detection of cancer. To discover novel hypermethylated genes in colorectal cancer by genome-wide search, we first defined a subset of genes epigenetically reactivated in colon cancer cells after treatment with a demethylating agent.

View Article and Find Full Text PDF

Context: Recently, tremendous efforts have been made towards the development of sensitive techniques to detect the BRAF(V600E) mutation in fine needle aspiration biopsy (FNAB) samples. However, newly developed quantitative and semi-quantitative methods, such as dual-priming oligonucleotide (DPO)-based multiplex polymerase chain reaction (PCR), have the potential to generate false-positive (FP) results.

Objectives: To eliminate the possibility of FP results, we generated a receiver operating characteristic (ROC) curve to investigate the diagnostic accuracy of pyrosequencing using quantitative data.

View Article and Find Full Text PDF
Article Synopsis
  • Dideoxy sequencing is the traditional method for detecting the BRAF(V600E) mutation in thyroid cancer but struggles with low mutant template levels in biopsy samples.
  • * Pyrosequencing, which directly measures the mutant template amounts, may provide more reliable results in cases with contamination from normal tissue.
  • * A study involving 101 thyroid incidentaloma cases found that pyrosequencing identified the BRAF(V600E) mutation in more cases compared to dideoxy sequencing, suggesting it may be a better diagnostic tool for these conditions.
View Article and Find Full Text PDF